The gut microbiota and the liver. Pathophysiological and clinical implications
dc.contributor.author | Quigley, Eamonn M. | |
dc.contributor.author | STANTON, CATHERINE | |
dc.contributor.author | Murphy, Eileen F. | |
dc.date.accessioned | 2020-06-18T11:11:14Z | |
dc.date.available | 2020-06-18T11:11:14Z | |
dc.date.issued | 2012-11-23 | |
dc.identifier.citation | Quigley, E., Stanton, C. and Murphy, E. (2013). The gut microbiota and the liver. Pathophysiological and clinical implications. Journal of Hepatology, [online] 58(5), pp.1020-1027. Available at: https://dx.doi.org/10.1016/j.jhep.2012.11.023. | en_US |
dc.identifier.uri | http://hdl.handle.net/11019/2016 | |
dc.description | peer-reviewed | en_US |
dc.description.abstract | This article reviews the microbiota in the pathogenesis of liver disease and its complications and the therapeutic impact of modulating the microbiota | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartofseries | Journal of Hepatology;Vol. 58 (5) | |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
dc.subject | Microbiota | en_US |
dc.subject | Bacteria | en_US |
dc.subject | Probiotics | en_US |
dc.subject | Prebiotics | en_US |
dc.subject | Antibiotics | en_US |
dc.subject | Liver | en_US |
dc.subject | Cirrhosis | en_US |
dc.subject | Hepatic encephalopathy | en_US |
dc.subject | Bacteraemia | en_US |
dc.title | The gut microbiota and the liver. Pathophysiological and clinical implications | en_US |
dc.type | Article | en_US |
dc.embargo.terms | 2013-11-23 | en_US |
dc.identifier.doi | https://dx.doi.org/10.1016/j.jhep.2012.11.023. | |
refterms.dateFOA | 2013-11-23T00:00:00Z |
Files in this item
This item appears in the following Collection(s)
-
Food Biosciences [559]